Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Cash flows from operating activities:
Net loss	$ (79,569)	$ (31,320)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	61,308	55,479
Loss on sale of investments		1,308
Amortization of deferred financing costs	7,856	2,394
Loss on extinguishment of debt	2,055
Share-based compensation expense	53,893
Loss on disposal of equipment and improvements	955
Undistributed earnings from unconsolidated investees	61	(67)
Gain on acquisition of unconsolidated investee	(8,659)
Accrued interest expense	(106)	915
Accrued interest income	(78)	(17)
Deferred rent	(359)	(36)
Deferred taxes	504	8,121
Loss on payment of contingent consideration	105
Reserve on uncollectible notes receivable	28	(19)
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable, net	5,822	(8,155)
Other receivables	3,993	1,044
Inventory	3,555	(924)
Other current assets	(5,165)	(5,293)
Other assets	53	4,847
Related parties	(3,001)	(14,499)
Accounts payable	(16,744)	(261)
Accrued expenses	28,900	11,970
Settlement processing funds, net	10,899	(22,304)
ISO reserves	42	(260)
Net cash provided by operating activities	66,348	2,923
Cash flows from investing activities:
Restricted cash		125,000
Acquisition of businesses, net of cash acquired	(48,547)	(124,964)
Purchase of equipment and improvements	(38,963)	(24,389)
Acquisition of intangible assets	(19,893)	(14,472)
Net proceeds from sale of investments		205
Issuance of notes receivable	(20)	(7)
Collections of notes receivable	91	968
Net cash used in investing activities	(107,332)	(37,659)
Cash flows from financing activities:
Proceeds from long-term debt	655,732	627,570
Repayments of long-term debt	(743,342)	(645,478)
Deferred financing costs paid	(3,899)	(19)
Contingent consideration paid	(1,621)
Deferred cash consideration paid	(65,000)
Acquisition of additional non-controlling interest	(16,916)
IPO proceeds, net of underwriter fees	231,500
Secondary offering proceeds, net of underwriter fees	24,967
Consideration paid for additional shares in a consolidated subsidiary		(3,962)
Contributions by members		71,250
Distribution to members		(1,708)
Distribution to non-controlling interests holders	(6,136)	(2,291)
Net cash provided by financing activities	75,285	45,362
Effect of exchange rate changes on cash and cash equivalents	(3,959)	13,460
Net increase in cash and cash equivalents	30,342	24,086
Cash and cash equivalents, beginning of year	205,142	203,324
Cash and cash equivalents, end of period	$ 235,484	$ 227,410